IMMUNE CHECKPOINT INHIBITORS
Case Studies
Section Editor
Barbara Rogers, CRNP, MN, AOCN®, ANP-BC
Fox Chase Cancer Center
Featured Case Study
Nivolumab-Associated Vasculitis in a Patient with Melanoma
Diagnosis
RG is a 60-year-old male in good condition diagnosed with cutaneous melanoma, with an ECOG performance status of 1...
Nivolumab-Associated Asystole in Patient With Metastatic Melanoma
Presentation and Diagnosis
Tom is an 87-year-old male patient with cardiovascular disease and diabetes who was diagnosed with melanoma of a lesion on his leg...
Nivolumab-Associated Pericarditis in a Patient With Non–Small Cell Lung Cancer
Diagnosis
NR is a 69-year-old male in good condition diagnosed with non–small cell lung cancer with a ECOG performance status of 0–1...
Nivolumab-Associated Myocarditis in a Patient With Metastatic Clear Cell Renal Cell Cancer
Presentation and Diagnosis
Jane is a 64-year-old female patient who was diagnosed with metastatic (to the lung) clear cell renal cancer in 2014...
Meet the Faculty
Videos
-
Immune Checkpoint Inhibitors Managing Cardiotoxicity Associated With Immune Checkpoint Inhibitor Therapy
-
Immune Checkpoint Inhibitors Immune Checkpoint Inhibitors and Cardiotoxicity: Incidence and Patient Risk Factors
-
Immune Checkpoint Inhibitors Immune Checkpoint Inhibitors and Cardiotoxicity: The Pharmacist Perspective
